Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/11/2012US8263550 Exendin agonist compounds
09/11/2012US8263549 C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
09/11/2012US8263548 Metal-binding compounds and uses therefor
09/11/2012US8263547 DISC-1 pathway activators in the control of neurogenesis
09/11/2012US8263546 Prevention and treatment of osteoarthritis
09/11/2012US8263545 GIP analog and hybrid polypeptides with selectable properties
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
09/11/2012US8263147 Infant formulas containing docosahexaenoic acid and lutein
09/11/2012US8263133 Multivalent clustering targeting strategy for drug carriers
09/11/2012US8263118 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
09/11/2012US8263108 Biodegradable insert; drug delivery
09/11/2012US8263095 Methods of use for peptides having activities of insulin like growth factor-1
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263080 Use of agonists and antagonists of IL-23 in the treatment of viral infection
09/11/2012US8263077 Cell growth inhibitors containing anti-glypican 3 antibody
09/11/2012US8263071 Protein involved in ovarian cancer
09/11/2012US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy
09/11/2012US8263064 Method of suppressing disease severity of multiple sclerosis using chemokine CXC11
09/11/2012US8263051 Photostabilization of resveratrol with alkoxycrylene compounds
09/11/2012US8263050 Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions
09/11/2012US8263046 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benz(enesulfon)amide and a second cooling agent, such as menthol or a derivative; similar cooling intensity to N-ethyl p-menthanecarboxamide (WS-3); ingestible or topical
09/11/2012US8261749 Augmentation and repair of vocal cord tissue defects
09/11/2012CA2549851C Macrocyclic peptides active against the hepatitis c virus
09/11/2012CA2525286C Materials and methods relating to g-protein coupled receptor oligomers
09/11/2012CA2506848C Prekallikrein depleted plasma derived albumin fraction
09/11/2012CA2489298C Novel antagonists of cxcr3-binding cxc chemokines
09/11/2012CA2486152C Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
09/11/2012CA2465245C Biologically active peptides and their use for repairing injured nerves
09/11/2012CA2448123C Taci-immunoglobulin fusion proteins
09/11/2012CA2423004C Peptide inhibitors of hiv entry
09/11/2012CA2395291C Five-helix protein
09/11/2012CA2374180C Methods and materials for generating sh3 domains with tailored binding properties
09/11/2012CA2272820C An improved method for the production and purification of adenoviral vectors
09/11/2012CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/07/2012WO2012119117A1 Vesicle compositions
09/07/2012WO2012119103A2 Compositions and methods for mobilization of stem cells
09/07/2012WO2012119093A1 Superagonists and antagonists of interleukin-2
09/07/2012WO2012119072A2 Compositions and methods for treatment of intracellular damage
09/07/2012WO2012119065A2 Antifungal agents and uses thereof
09/07/2012WO2012119007A1 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
09/07/2012WO2012119004A2 Parathyroid hormone analogs, compositions and uses thereof
09/07/2012WO2012118930A2 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/07/2012WO2012118863A1 Therapies that target autoimmunity for treating glaucoma and optic neuropathy
09/07/2012WO2012118821A2 Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis
09/07/2012WO2012118778A1 Truncated car peptides and methods and compositions using truncated car peptides
09/07/2012WO2012118717A2 Coupling endonucleases with end-processing enzymes drive high efficiency gene disruption
09/07/2012WO2012118388A1 Peptide-lipid constructs and their use in a fc-function assay
09/07/2012WO2012118353A2 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
09/07/2012WO2012118323A2 Fusion protein comprising albumin and a retinol-binding protein
09/07/2012WO2012118237A1 Anti-cancer prodrug activated by radiation or ultraviolet therapy and use thereof
09/07/2012WO2012118124A1 Novel chemokine receptor antagonist
09/07/2012WO2012118070A1 Anti-gram-negative bacteria agent
09/07/2012WO2012118042A1 Medicinal agent for inhibiting metastasis of malignant tumor
09/07/2012WO2012117688A1 Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier, each containing same
09/07/2012WO2012117592A1 Therapeutic agent for hyperthermia
09/07/2012WO2012117297A1 Isolated laminin-421
09/07/2012WO2012117203A1 Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor
09/07/2012WO2012117136A1 Lactoferrin hydrolysate fraction with a low molecular weight for treating hypertension
09/07/2012WO2012117091A1 Coagulation factor-targeting to tlt-1 on activated platelets
09/07/2012WO2012117012A1 Composition for nutrition purposes
09/07/2012WO2012116663A1 Anticoagulant polypeptide and applications thereof
09/07/2012WO2012116439A1 Biomaterial, method for making the biomaterial and uses of the same
09/07/2012WO2012116402A1 Binder powders
09/07/2012WO2012097333A3 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
09/07/2012WO2012097123A3 New uses of cyclophilin inhibitors
09/07/2012WO2012096893A3 Antigen surrogates in autoimmune disease
09/07/2012WO2012093931A8 Antimicrobial fusion compounds and uses thereof
09/07/2012WO2012091946A3 Method for inhibiting pathogens using a nutritional composition
09/07/2012WO2012047354A3 Environmentally sensitive compositions
09/07/2012CA2829020A1 Parathyroid hormone analogs, compositions and uses thereof
09/07/2012CA2828789A1 Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor
09/07/2012CA2828769A1 Coagulation factor-targeting to tlt-1 on activated platelets
09/07/2012CA2828572A1 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
09/07/2012CA2828303A1 Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
09/07/2012CA2828016A1 Biomaterial, method for making the biomaterial and uses of the same
09/07/2012CA2822021A1 Vesicle compositions
09/06/2012US20120227120 Hydrolases, nucleic acids encoding them and methods for making and using them
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120226224 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
09/06/2012US20120226090 Protection Against and Treatment of Ionizing Radiation
09/06/2012US20120226072 Processes for intermediates for macrocyclic compounds
09/06/2012US20120226067 Processes for intermediates for macrocyclic compounds
09/06/2012US20120226066 Processes for intermediates for macrocyclic compounds
09/06/2012US20120225940 Use of (-) (3-Trihalomethylphenoxy) (4-Halophenyl) Acetic Acid Derivatives for Treatment of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia and Hyperuricemia
09/06/2012US20120225930 Method of treating or retarding the development of blindness
09/06/2012US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
09/06/2012US20120225843 Use of Sulfated Glycosaminoglycans for Establishing Effective Labor in Women
09/06/2012US20120225831 Melanocortin-1 Receptor-Specific Linear Peptides
09/06/2012US20120225830 Method of producing fr901228
09/06/2012US20120225829 Method of producing fr901228
09/06/2012US20120225828 Melanocortin-1 Receptor-Specific Cyclic Peptides
09/06/2012US20120225827 Silicone-based ophthalmic formulations
09/06/2012US20120225826 Transporters Comprising Spaced Arginine Moieties
09/06/2012US20120225825 Cyclodextrin-based polymers for therapeutic delivery
09/06/2012US20120225824 Mullerian inhibiting substance (mis) analogues
09/06/2012US20120225823 Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction
09/06/2012US20120225822 Peptides for the treatment of oxidative stress related disorders
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 3163